Cargando…
Identification of proteins and signalling pathways involved in neoadjuvant chemotherapy responsiveness of breast tumours using proteomics
Autores principales: | Greenwood, CR, Alldridge, LC, Sekharan, S Chandra, Al-Janabi, K, Sauven, P, Souchelnytskyi, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875602/ http://dx.doi.org/10.1186/bcr2537 |
Ejemplares similares
-
Optimized Protocol for Protein Extraction from the Breast Tissue that is Compatible with Two-Dimensional Gel Electrophoresis
por: Zakharchenko, Olena, et al.
Publicado: (2011) -
Does imaging correctly influence the surgical management in the setting of neoadjuvant chemotherapy?
por: Fatayer, H, et al.
Publicado: (2012) -
Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
por: Shehata, M, et al.
Publicado: (2010) -
PB.34. Marker clip placement may not be needed in breast cancer patients undergoing neoadjuvant chemotherapy with a view to breast-conserving surgery whose tumours are associated with microcalcification
por: Sreenivas, M
Publicado: (2014) -
Correlation of post-neoadjuvant chemotherapy response on MRI with final histology in breast cancer patients
por: Mahatma, Anjum, et al.
Publicado: (2015)